General Information of the Compound
Compound ID
CP0489617
Compound Name
N-[2-[(3-cyano-5,7-dimethylquinolin-2-yl)amino]ethyl]pyridine-4-carboxamide
    Show/Hide
Structure
Formula
C20H19N5O
Molecular Weight
345.406
Canonical SMILES
Cc1cc(C)c2cc(C#N)c(NCCNC(=O)c3ccncc3)nc2c1
    Show/Hide
InChI
InChI=1S/C20H19N5O/c1-13-9-14(2)17-11-16(12-21)19(25-18(17)10-13)23-7-8-24-20(26)15-3-5-22-6-4-15/h3-6,9-11H,7-8H2,1-2H3,(H,23,25)(H,24,26)
    Show/Hide
InChIKey
NHEFELIQQRRHSB-UHFFFAOYSA-N
Physicochemical Property
logP
2.96022
Rotatable Bonds
5
Heavy Atom Count
26
Polar Areas
90.7
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
5
Complexity
26

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 53382960
SID: 135666963
ChEMBL ID
CHEMBL2018578
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02042, Cystic fibrosis transmembrane conductance regulator
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000535 CFBE41o- Homo sapiens (Human)  1
1
EC50 = 7244.36 nM
   TI
   LI
   LO
   TS
CL000259 FRT Rattus norvegicus (Rat)  1
1
EC50 = 7300 nM
   TI
   LI
   LO
   TS